Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pathologic Complete Response”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05206396
What this trial is testing

TIL Relation to pCR After Neoadjuvant Therapy in Breast Cancer Patients

Who this might be right for
Breast Cancer
Ain Shams University 270
Testing effectiveness (Phase 2)UnknownNCT02059876
What this trial is testing

Dose-dense (Biweekly) Carboplatin Plus Paclitaxel With or Without Trastuzumab as Neoadjuvant Treatment for Breast Cancer

Who this might be right for
Breast Cancer
Guangdong Provincial People's Hospital 60
Testing effectiveness (Phase 2)Study completedNCT01266083
What this trial is testing

WT1 Vaccine Treatment of Patients in Remission From Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic Leukemia
Sellas Life Sciences Group 22
Large-scale testing (Phase 3)Study completedNCT04232423
What this trial is testing

Olanzapine for Chemotherapy-induced Nausea and Vomiting Prophylaxis

Who this might be right for
Complete Response Rate to Chemotherapy-induced Nausea and Vomiting Prophylaxis
Department of Medical Services Ministry of Public Health of Thailand 90
Large-scale testing (Phase 3)Active Not RecruitingNCT04229979
What this trial is testing

Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2

Who this might be right for
Acute Myeloid Leukemia
Sellas Life Sciences Group 127
Not applicableStudy completedNCT06854107
What this trial is testing

Intratumoral and Peritumoral Habitat Radiomics of MRI Predict Pathologic Complete Response to Neoadjuvant Chemoimmunotherapy in Oral Squamous Cell Carcinoma

Who this might be right for
Pathologic Complete Response
Zilong Yuan 225
Not applicableNot Yet RecruitingNCT07673211
What this trial is testing

Circulating cfDNA and HPV as Prognostic Biomarkers for First-Line Recurrent Metastatic Cervical Cancer

Who this might be right for
Cervical CancerRecurrent Cervical CancerMetastatic Cervical Cancer
Zhejiang Cancer Hospital 60
Large-scale testing (Phase 3)Study completedNCT01648894
What this trial is testing

Influence of Lengthening the Interval Between Radiochemotherapy and Surgery on Complete Pathological Response in Rectal Cancer

Who this might be right for
Rectal Cancer
Assistance Publique - Hôpitaux de Paris 265
Not applicableLooking for participantsNCT05350722
What this trial is testing

Single-dose Preoperative Partial Breast Irradiation in Low-risk Breast Cancer Patients

Who this might be right for
Breast Cancer
Amsterdam UMC, location VUmc 100
Testing effectiveness (Phase 2)Looking for participantsNCT06927180
What this trial is testing

SHR-A1811 Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BC

Who this might be right for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Henan Cancer Hospital 180
Post-approval studies (Phase 4)Study completedNCT01735955
What this trial is testing

Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study

Who this might be right for
Chronic Myelogenous Leukemia (CML)Metastatic Gastrointestinal Stromal Tumors (GIST)Acute Lymphoblastic Leukemia (ALL)+1 more
Novartis Pharmaceuticals 57
Testing effectiveness (Phase 2)Active Not RecruitingNCT03192397
What this trial is testing

Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

Who this might be right for
Acute Myeloid Leukemia in RemissionAdult Acute Lymphoblastic Leukemia in Complete RemissionChronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission+10 more
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Looking for participantsNCT07586813
What this trial is testing

Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid Tumors

Who this might be right for
Persistent Isolated Chemotherapy-Induced ThrombocytopeniaChemotherapy-Induced ThrombocytopeniaGastrointestinal Neoplasms+2 more
Peking University People's Hospital 220
Testing effectiveness (Phase 2)Looking for participantsNCT07407920
What this trial is testing

Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Early Stage HER2-Positive Breast Carcinoma+1 more
M.D. Anderson Cancer Center 120
Not applicableNot Yet RecruitingNCT07663084
What this trial is testing

CBC Indices and Serum Lactate in Neonatal Sepsis

Who this might be right for
Neonatal SepsisSepsis
Assiut University 80
Not applicableWithdrawnNCT01956513
What this trial is testing

Contribution of MRI in the Evaluation of Apparent Diffusion Coefficient and Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer

Who this might be right for
Assess the Variation of Apparent Diffusion Coefficient
Centre Jean Perrin
Testing effectiveness (Phase 2)Active Not RecruitingNCT07127497
What this trial is testing

Clinical Study on the Safety and Relationship of Sintilimab Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma

Who this might be right for
Pathological Complete ResponseRectal CancerNeoadjuvant Chemoimmunotherapy
The First Affiliated Hospital of Anhui Medical University 50
Not applicableNot Yet RecruitingNCT07764341
What this trial is testing

Supervised Exercise During Neoadjuvant Chemotherapy for Breast Cancer

Who this might be right for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)Breast Neoplasm Malignant Female
King Hamad University Hospital, Bahrain 80
Not applicableActive Not RecruitingNCT06087718
What this trial is testing

Feasibility of the Maastro Applicator in Rectal Cancer

Who this might be right for
Rectal CancerFeasibilityToxicity+5 more
Maastricht Radiation Oncology 10
Early research (Phase 1)Looking for participantsNCT06130995
What this trial is testing

Relugolix + Enzalutamide Study in High-Risk Prostate Cancer

Who this might be right for
Androgen Deprivation TherapyLocally Advanced Prostate Cancer
University of Oklahoma 46
Next Page
35